IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

PCI Synthesis: Increased regulatory scrutiny, wage inflations in India and China to impact industry in 2014

7:35 AM MST | December 10, 2013 | Deepti Ramesh

PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities, generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty chemical products, has announced a list of trends that are likely to impact the generic drug and emerging biotech industries in 2014. The trends include increased regulatory scrutiny, drug shortages, wage inflations in India and China, a biotech bubble, and the challenge of finding qualified people. FDA—most recently with a bill signed into law in November 2013, the Drug Quality...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa